Reports

Browse current and previous editions of Switzer Report

Monday Edition, 3 February 2025
James Dunn

Best of the top 20 stocks

James Dunn · February 3, 2025

Is there value in the S&P/ASX 20 right now? Here’s a look at four ‘buy’ prospects from the ASX’s top echelon: Telstra, Rio Tinto, BHP and CSL.

Investing Premium
Switzer on Saturday, 1 February 2025
Thursday Edition, 30 January 2025
Paul Rickard

Two top picks for 2025

Paul Rickard · January 30, 2025

While it’s hard to identify stocks I want to buy in this ‘expensive’ market, here are two suggestions, for different reasons and different objectives – yield and growth.

Investing Premium
Tony Featherstone

Two options for listed property

Tony Featherstone · January 30, 2025

Always looking for sensible contrarian investments, Toney Featherstone pinpoints two ways to get exposure to data centres, office, retail and other assets, at a time when falling interest rates and pressure for workers to go back to the office might be game changing pluses for this sectors’ stocks.

Investing Premium
Maureen Jordan

“HOT” stock 1: Magellan Financial (MFG)

Maureen Jordan · January 30, 2025

In our “HOT” stock article today, Michael Gable, MD of Fairmont Equities, explains why any breakout from its current base could lead to a significant multi-month move in Magellan Financial (MFG).

Investing Premium
Maureen Jordan

“HOT” stock 2: Megaport MP1

Maureen Jordan · January 30, 2025

In our second “HOT” stock article today, Raymond Chan, Head of Asian Desk at Morgans explains why he regards Megaport (MP1) as an ADD to an investor’s portfolio.

Investing Premium
James Dunn

Two Medical Imaging Stars

James Dunn · January 30, 2025

Here are two Australian medical device companies doing impressive things in the medical imaging area in Australia and the US.

Investing Premium
Paul Rickard

Questions of the Week

Paul Rickard · January 30, 2025

Why has Treasury Wine Estates tanked? I would like to diversify into Australian and international bonds. Is there a bond broker you can recommend? What are your thoughts on the Global Defence ETF (DFND)? What upside do the brokers see for Cyclopharm (CYC)?

Q&A Premium
Switzer on Saturday, 25 January 2025
Peter Switzer

The Trump rally continues but next week could be testing

Peter Switzer · January 25, 2025

Although Wall Street took a breather on Friday, the Trump-inspired rally has rolled on for another week, undoubtedly explained by profit-takers unable to resist pocketing some of the near 7% gains since the new president won the November 5 poll last year.

Switzer on Saturday Premium
Thursday Edition, 23 January 2025
1 52 53 54 55 56 124

You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.